Nanoliposomal irinotecan in metastatic pancreatic cancer

doi:10.1016/S0140-6736(16)30463-9

Comment

. 2016 May 14;387(10032):1997.

doi: 10.1016/S0140-6736(16)30463-9.

Nanoliposomal irinotecan in metastatic pancreatic cancer

Ioan Milosevic¹, Henry Drysdale², Ben Goldacre²; COMPare project team

Affiliations

¹ Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Services, Oxford, OX2 6GG, UK. Electronic address: compare-team@ebmdatalab.net.
² Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Services, Oxford, OX2 6GG, UK.

PMID: 27203772
DOI: 10.1016/S0140-6736(16)30463-9

Comment

Nanoliposomal irinotecan in metastatic pancreatic cancer

Ioan Milosevic et al. Lancet. 2016.

. 2016 May 14;387(10032):1997.

doi: 10.1016/S0140-6736(16)30463-9.

Authors

Ioan Milosevic¹, Henry Drysdale², Ben Goldacre²; COMPare project team

Affiliations

¹ Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Services, Oxford, OX2 6GG, UK. Electronic address: compare-team@ebmdatalab.net.
² Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Services, Oxford, OX2 6GG, UK.

PMID: 27203772
DOI: 10.1016/S0140-6736(16)30463-9

No abstract available

PubMed Disclaimer

Comment in

Nanoliposomal irinotecan in metastatic pancreatic cancer - Authors' reply.
Chen LT, Wang-Gillam A, Von Hoff DD, Bayever E, Belanger B. Chen LT, et al. Lancet. 2016 May 14;387(10032):1997. doi: 10.1016/S0140-6736(16)30365-8. Lancet. 2016. PMID: 27203770 No abstract available.

Comment on

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.
Wang-Gillam A, Li CP, Bodoky G, Dean A, Shan YS, Jameson G, Macarulla T, Lee KH, Cunningham D, Blanc JF, Hubner RA, Chiu CF, Schwartsmann G, Siveke JT, Braiteh F, Moyo V, Belanger B, Dhindsa N, Bayever E, Von Hoff DD, Chen LT; NAPOLI-1 Study Group. Wang-Gillam A, et al. Lancet. 2016 Feb 6;387(10018):545-557. doi: 10.1016/S0140-6736(15)00986-1. Epub 2015 Nov 29. Lancet. 2016. PMID: 26615328 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Nanoliposomal irinotecan in metastatic pancreatic cancer

Affiliations

Nanoliposomal irinotecan in metastatic pancreatic cancer

Authors

Affiliations

Comment in

Comment on

Similar articles

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical